Francois-xavier Legrand

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 49 publications

Quercetin crystal-stabilized pickering emulsions: altering droplet shape via oil polarity.

Quercetin crystal-stabilized pickering emulsions: altering droplet shape via oil polarity.

Journal: International journal of pharmaceutics

Published: March 16, 2026

Hospital 3D-printed cyclophosphamide printlets for paediatric patients.

Hospital 3D-printed cyclophosphamide printlets for paediatric patients.

Journal: International journal of pharmaceutics

Published: February 20, 2026

Hospital-Compounded Birabresib Capsules for NUT Carcinoma: A Quality- and Risk-Based CMC Strategy.

Hospital-Compounded Birabresib Capsules for NUT Carcinoma: A Quality- and Risk-Based CMC Strategy.

Journal: Pharmaceutical research

Published: January 16, 2026

Hybrid GPP-hospital control strategy for semi-solid extrusion 3D printing of ONC201 chewable units in pediatric oncology.

Hybrid GPP-hospital control strategy for semi-solid extrusion 3D printing of ONC201 chewable units in pediatric oncology.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: August 22, 2025

Are hydrophilic deep eutectic solvents a potential vehicle for topical delivery of Amphotericin B against cutaneous leishmaniasis? An investigation of physicochemical properties, tolerability and antileishmanial efficacy.

Are hydrophilic deep eutectic solvents a potential vehicle for topical delivery of Amphotericin B against cutaneous leishmaniasis? An investigation of physicochemical properties, tolerability and antileishmanial efficacy.

Journal: International journal of pharmaceutics

Published: August 16, 2025

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.

HPV circulating tumor DNA to monitor response to pembrolizumab and vorinostat combination in patients with advanced HPV-related squamous-cell carcinomas.

Journal: ESMO open

Published: June 06, 2025

Improvement of the rheological properties and performance of liquid crystal emulsions: influence of oil addition and/or high-frequency ultrasound treatment.

Improvement of the rheological properties and performance of liquid crystal emulsions: influence of oil addition and/or high-frequency ultrasound treatment.

Journal: International journal of pharmaceutics

Published: May 26, 2025

Tremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE study.

Tremelimumab plus durvalumab combined to metronomic oral vinorelbine: Results from the breast cancer cohort of the phase II MOVIE study.

Journal: Breast (Edinburgh, Scotland)

Published: April 29, 2025

Porous ionic liquids based on biocompatible CD-MOFs.

Porous ionic liquids based on biocompatible CD-MOFs.

Journal: Chemical communications (Cambridge, England)

Published: March 24, 2025

Clinical implementation of a paediatric 3D-printed combination of Sulfamethoxazole and Trimethoprim.

Clinical implementation of a paediatric 3D-printed combination of Sulfamethoxazole and Trimethoprim.

Journal: International journal of pharmaceutics

Published: February 04, 2025

MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer.

MOVIE phase II trial of tremelimumab plus durvalumab combined with metronomic oral vinorelbine in patients with head and neck cancer.

Journal: ESMO open

Published: January 21, 2025

Repurposing chlorpromazine for anti-leukaemic therapy with the drug-in-cyclodextrin-in-liposome nanocarrier platform.

Repurposing chlorpromazine for anti-leukaemic therapy with the drug-in-cyclodextrin-in-liposome nanocarrier platform.

Journal: Carbohydrate polymers

Published: December 23, 2024

Showing 1-12 of 49

Last Updated: 09/26/2026